Retaglutide and tirzepatide are groundbreaking GLP-1 receptor agonists gaining recognition as effective treatment options for type 2 diabetes. These medications stimulate insulin secretion from the pancreas, inhibit https://lewysnugx590961.wikicorrespondence.com/6080696/emerging_therapies_for_type_2_diabetes